These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20724264)

  • 1. Homozygous Machado Joseph Disease: a case report and review of literature.
    Lysenko L; Grewal RP; Ma W; Peddareddygari LR
    Can J Neurol Sci; 2010 Jul; 37(4):521-3. PubMed ID: 20724264
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease.
    Nascimento-Ferreira I; Santos-Ferreira T; Sousa-Ferreira L; Auregan G; Onofre I; Alves S; Dufour N; Colomer Gould VF; Koeppen A; Déglon N; Pereira de Almeida L
    Brain; 2011 May; 134(Pt 5):1400-15. PubMed ID: 21478185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analyses of Machado-Joseph disease.
    Kobayashi T; Kakizuka A
    Cytogenet Genome Res; 2003; 100(1-4):261-75. PubMed ID: 14526188
    [No Abstract]   [Full Text] [Related]  

  • 4. Does DNA methylation in the promoter region of the ATXN3 gene modify age at onset in MJD (SCA3) patients?
    Emmel VE; Alonso I; Jardim LB; Saraiva-Pereira ML; Sequeiros J
    Clin Genet; 2011 Jan; 79(1):100-2. PubMed ID: 21143471
    [No Abstract]   [Full Text] [Related]  

  • 5. SCA3 presenting as an isolated axonal polyneuropathy.
    Graves TD; Guiloff RJ
    Arch Neurol; 2011 May; 68(5):653-5. PubMed ID: 21555642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygosity enhances severity in spinocerebellar ataxia type 3.
    Carvalho DR; La Rocque-Ferreira A; Rizzo IM; Imamura EU; Speck-Martins CE
    Pediatr Neurol; 2008 Apr; 38(4):296-9. PubMed ID: 18358414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological crying in patients with Machado-Joseph disease.
    Guimarães J; Bugalho P; Coutinho P
    Mov Disord; 2008 Feb; 23(3):470-1. PubMed ID: 18098278
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent advances in molecular genetics of spinocerebellar ataxia type 3/Machado-Joseph disease].
    Jia D; Jiang H; Tang B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):660-2. PubMed ID: 19065526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.
    Silva-Fernandes A; Costa Mdo C; Duarte-Silva S; Oliveira P; Botelho CM; Martins L; Mariz JA; Ferreira T; Ribeiro F; Correia-Neves M; Costa C; Maciel P
    Neurobiol Dis; 2010 Oct; 40(1):163-76. PubMed ID: 20510362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaicism of the CAG repeat in CNS tissue in relation to age at death in spinocerebellar ataxia type 1 and Machado-Joseph disease patients.
    Maciel P; Lopes-Cendes I; Kish S; Sequeiros J; Rouleau GA
    Am J Hum Genet; 1997 Apr; 60(4):993-6. PubMed ID: 9106546
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype.
    van Alfen N; Sinke RJ; Zwarts MJ; Gabreëls-Festen A; Praamstra P; Kremer BP; Horstink MW
    Ann Neurol; 2001 Jun; 49(6):805-7. PubMed ID: 11409435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved polymerase chain reaction method for genetic testing of spinocerebellar ataxia type 3.
    Sun WP; He XH; Yu LQ; Wang DP; Qin ZhH; Fang Q; Wang J
    Genetika; 2011 Oct; 47(10):1416-9. PubMed ID: 22232931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spastic paraparesis as the first manifestation of Machado-Joseph disease: A case report and review of the literature.
    Lin HC; Chang YY; Chang KH; Chen YF; Lan MY
    Clin Neurol Neurosurg; 2018 Sep; 172():137-140. PubMed ID: 30007589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
    Gonçalves N; Simões AT; Cunha RA; de Almeida LP
    Ann Neurol; 2013 May; 73(5):655-66. PubMed ID: 23625556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A small 55-repeat MJD1 CAG allele in a patient with Machado-Joseph disease and abnormal eye movements.
    Egan RA; Camicioli R; Popovich BW
    Eur Neurol; 2000; 44(3):189-90. PubMed ID: 11053973
    [No Abstract]   [Full Text] [Related]  

  • 16. The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls.
    Bettencourt C; Santos C; Montiel R; Kay T; Vasconcelos J; Maciel P; Lima M
    Eur J Hum Genet; 2010 May; 18(5):621-3. PubMed ID: 19935829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival estimates for patients with Machado-Joseph disease (SCA3).
    Kieling C; Prestes PR; Saraiva-Pereira ML; Jardim LB
    Clin Genet; 2007 Dec; 72(6):543-5. PubMed ID: 17894834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population genetics of wild-type CAG repeats in the Machado-Joseph disease gene in Portugal.
    Lima M; Costa MC; Montiel R; Ferro A; Santos C; Silva C; Bettencourt C; Sousa A; Sequeiros J; Coutinho P; Maciel P
    Hum Hered; 2005; 60(3):156-63. PubMed ID: 16340213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A spinocerebellar ataxia family with expanded alleles in the TATA-binding protein gene and ataxin-3 gene.
    Xu Q; Li Q; Wang J; Jiang H; Shen L; Li X; Tang B
    Int J Neurosci; 2010 Feb; 120(2):159-61. PubMed ID: 20199210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?
    Alves S; Nascimento-Ferreira I; Dufour N; Hassig R; Auregan G; Nóbrega C; Brouillet E; Hantraye P; Pedroso de Lima MC; Déglon N; de Almeida LP
    Hum Mol Genet; 2010 Jun; 19(12):2380-94. PubMed ID: 20308049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.